210 related articles for article (PubMed ID: 30877197)
1. ATP-citrate lyase multimerization is required for coenzyme-A substrate binding and catalysis.
Bazilevsky GA; Affronti HC; Wei X; Campbell SL; Wellen KE; Marmorstein R
J Biol Chem; 2019 May; 294(18):7259-7268. PubMed ID: 30877197
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis for acetyl-CoA production by ATP-citrate lyase.
Wei X; Schultz K; Bazilevsky GA; Vogt A; Marmorstein R
Nat Struct Mol Biol; 2020 Jan; 27(1):33-41. PubMed ID: 31873304
[TBL] [Abstract][Full Text] [Related]
3. Allosteric role of the citrate synthase homology domain of ATP citrate lyase.
Wei X; Schultz K; Pepper HL; Megill E; Vogt A; Snyder NW; Marmorstein R
Nat Commun; 2023 Apr; 14(1):2247. PubMed ID: 37076498
[TBL] [Abstract][Full Text] [Related]
4. Identification of the citrate-binding site of human ATP-citrate lyase using X-ray crystallography.
Sun T; Hayakawa K; Bateman KS; Fraser ME
J Biol Chem; 2010 Aug; 285(35):27418-27428. PubMed ID: 20558738
[TBL] [Abstract][Full Text] [Related]
5. Modulation of matrix metabolism by ATP-citrate lyase in articular chondrocytes.
Chen LY; Lotz M; Terkeltaub R; Liu-Bryan R
J Biol Chem; 2018 Aug; 293(31):12259-12270. PubMed ID: 29929979
[TBL] [Abstract][Full Text] [Related]
6. Structure of ATP citrate lyase and the origin of citrate synthase in the Krebs cycle.
Verschueren KHG; Blanchet C; Felix J; Dansercoer A; De Vos D; Bloch Y; Van Beeumen J; Svergun D; Gutsche I; Savvides SN; Verstraete K
Nature; 2019 Apr; 568(7753):571-575. PubMed ID: 30944476
[TBL] [Abstract][Full Text] [Related]
7. An allosteric mechanism for potent inhibition of human ATP-citrate lyase.
Wei J; Leit S; Kuai J; Therrien E; Rafi S; Harwood HJ; DeLaBarre B; Tong L
Nature; 2019 Apr; 568(7753):566-570. PubMed ID: 30944472
[TBL] [Abstract][Full Text] [Related]
8. Identification of the active site residues in ATP-citrate lyase's carboxy-terminal portion.
Nguyen VH; Singh N; Medina A; Usón I; Fraser ME
Protein Sci; 2019 Oct; 28(10):1840-1849. PubMed ID: 31411782
[TBL] [Abstract][Full Text] [Related]
9. Polyamine regulating protein antizyme binds to ATP citrate lyase to accelerate acetyl-CoA production in cancer cells.
Tajima A; Murai N; Murakami Y; Iwamoto T; Migita T; Matsufuji S
Biochem Biophys Res Commun; 2016 Mar; 471(4):646-51. PubMed ID: 26915799
[TBL] [Abstract][Full Text] [Related]
10. Mammalian SIRT6 Represses Invasive Cancer Cell Phenotypes through ATP Citrate Lyase (ACLY)-Dependent Histone Acetylation.
Zheng W; Tasselli L; Li TM; Chua KF
Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573442
[TBL] [Abstract][Full Text] [Related]
11. ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism.
Granchi C
Eur J Med Chem; 2018 Sep; 157():1276-1291. PubMed ID: 30195238
[TBL] [Abstract][Full Text] [Related]
12. ATP citrate lyase: A central metabolic enzyme in cancer.
Icard P; Wu Z; Fournel L; Coquerel A; Lincet H; Alifano M
Cancer Lett; 2020 Feb; 471():125-134. PubMed ID: 31830561
[TBL] [Abstract][Full Text] [Related]
13. ATP-citrate lyase deficiency in the mouse.
Beigneux AP; Kosinski C; Gavino B; Horton JD; Skarnes WC; Young SG
J Biol Chem; 2004 Mar; 279(10):9557-64. PubMed ID: 14662765
[TBL] [Abstract][Full Text] [Related]
14. ATP citrate lyase knockdown induces growth arrest and apoptosis through different cell- and environment-dependent mechanisms.
Zaidi N; Royaux I; Swinnen JV; Smans K
Mol Cancer Ther; 2012 Sep; 11(9):1925-35. PubMed ID: 22718913
[TBL] [Abstract][Full Text] [Related]
15. Polarization of Human Macrophages by Interleukin-4 Does Not Require ATP-Citrate Lyase.
Namgaladze D; Zukunft S; Schnütgen F; Kurrle N; Fleming I; Fuhrmann D; Brüne B
Front Immunol; 2018; 9():2858. PubMed ID: 30568658
[TBL] [Abstract][Full Text] [Related]
16. ATP-Citrate Lyase Controls a Glucose-to-Acetate Metabolic Switch.
Zhao S; Torres A; Henry RA; Trefely S; Wallace M; Lee JV; Carrer A; Sengupta A; Campbell SL; Kuo YM; Frey AJ; Meurs N; Viola JM; Blair IA; Weljie AM; Metallo CM; Snyder NW; Andrews AJ; Wellen KE
Cell Rep; 2016 Oct; 17(4):1037-1052. PubMed ID: 27760311
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Role of ATP-Citrate Lyase in the Immune System.
Dominguez M; Brüne B; Namgaladze D
Front Immunol; 2021; 12():632526. PubMed ID: 33679780
[TBL] [Abstract][Full Text] [Related]
18. Active post-transcriptional regulation and ACLY-mediated acetyl-CoA synthesis as a pivotal target of Shuang-Huang-Sheng-Bai formula for lung adenocarcinoma treatment.
Liu D; Dong C; Wang F; Liu W; Jin X; Qi SL; Liu L; Jin Q; Wang S; Wu J; Wang C; Yang J; Deng H; Cai Y; Yang L; Qin J; Zhang C; Yang X; Wang MS; Yu G; Xue YW; Wang Z; Ge GB; Xu Z; Chen WL
Phytomedicine; 2023 May; 113():154732. PubMed ID: 36933457
[TBL] [Abstract][Full Text] [Related]
19. ATP-citrate lyase reduction mediates palmitate-induced apoptosis in pancreatic beta cells.
Chu KY; Lin Y; Hendel A; Kulpa JE; Brownsey RW; Johnson JD
J Biol Chem; 2010 Oct; 285(42):32606-15. PubMed ID: 20693577
[TBL] [Abstract][Full Text] [Related]
20. ATP-citrate lyase regulates cellular senescence via an AMPK- and p53-dependent pathway.
Lee JH; Jang H; Lee SM; Lee JE; Choi J; Kim TW; Cho EJ; Youn HD
FEBS J; 2015 Jan; 282(2):361-71. PubMed ID: 25367309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
